Lujia Huang

机构：Shanghai Institute of Materia Medica, University of Chinese Academy of Sciences · ORCID：0000-0002-9574-9174

发表论文 17 篇 · 总被引 656 次 · h-index 11

代表论文

• Acid‐Ionizable Iron Nanoadjuvant Augments STING Activation for Personalized Vaccination Immunotherapy of Cancer (2022 · Advanced Materials · 被引 126)
• From structural design to delivery: mRNA therapeutics for cancer immunotherapy (2023 · Exploration · 被引 111)
• Smart and versatile biomaterials for cutaneous wound healing (2023 · Biomaterials Research · 被引 101)
• Nanovesicles loaded with a TGF-β receptor 1 inhibitor overcome immune resistance to potentiate cancer immunotherapy (2023 · Nature Communications · 被引 86)
• Engineered nanomedicines block the PD-1/PD-L1 axis for potentiated cancer immunotherapy (2022 · Acta Pharmacologica Sinica · 被引 43)
• Redox Dyshomeostasis with Dual Stimuli‐Activatable Dihydroartemisinin Nanoparticles to Potentiate Ferroptotic Therapy of Pancreatic Cancer (2022 · Small Methods · 被引 39)